A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R | MicrobiomeTrials← Back to trialsNCT06717360
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R
CompletedPHASE3INTERVENTIONAL
Trial Details
Start: 2024-09-30Est. Completion: 2025-07-10
Enrollment target: 158 participants Locations- AhnGook, Seoul, South Korea
Other microbiome trials you might be interested in
HypercholesterolemiaAtherosclerosis
This study will evaluate people with dyslipidemias - disorders that affect the fat content in the blood. Fats, or lipids…
Bethesda, United States
HypercholesterolemiaDyslipidemia
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
Seoul, South KoreaEst. completion Jun 26, 2026